Mumbai (Maharashtra) [India], May 9: Mitsu Chem Plast Limited (Mitsu) (BSE:540078), one of the leading global manufacturers of Blow moulded & Injection Moulded products and a specialist in hospital furniture components, Infrastructure Products, Packaging Bottles Drums, Jerrycan, Pails and Caps, has announced its Audited Financial Results for Q4 FY25 & FY25.
Key Financial Highlights Q4 FY25
* Total Income of ₹ 90.51 Cr, YoY growth of 9.64%
* EBITDA of ₹ 8.23 Cr, YoY growth of 9.39%
* PAT of ₹ 3.54 Cr, YoY growth of 25.11%
* PAT Margin of 3.91%, YoY growth of 47 Bps
* EPS of ₹ 2.61, YoY growth of 14.98%
Commenting on the performance, Mr. Jagdish Dedhia, Chairman of Mitsu Chem Plast Limited said,“In FY25, we delivered a total income of ₹ 332.88 Cr, an EBITDA of ₹ 23.28 Cr, a PAT of ₹ 7.25 Cr and an EPS of ₹ 5.39, figures that underscore the resilience and balanced execution of our business model.
We’re also proud of the strong export momentum we’ve built, proof of our product quality and the trust of partners around the world which has paved the way for Furnastra, our dedicated healthcare-furniture brand designed to meet rising demand for durable, ergonomic solutions in hospitals and care facilities. Sustainability underpins everything we do, from sourcing eco-friendly materials to driving energy and waste efficiencies in our operations.
Looking ahead, we’ve set our sights on reaching the ₹ 1,000 Cr milestone by 2028 a goal that extends our 35-year legacy of innovation and customer focus. It’s not just about scaling revenues; it’s about improving patient care worldwide through Furnastra’s advanced polymer solutions. With our export strength, targeted brand expansion, and unwavering commitment to sustainable practices, we’re well-positioned to capture new opportunities and deliver lasting value for all stakeholders.”
Key Operational Highlights
Mitsu Chem unveiled Furnastra, a dedicated brand exclusively for healthcare furniture solutions.
Strategic Move:
Marks a pivotal shift in Mitsu Chem’s strategy to provide a distinct identity to its well-established healthcare furniture line.
Core Offerings Under Furnastra:
• Built to Last: Engineered for durability and high performance in demanding healthcare settings.
• Smart & Comfortable Design: Combines modern ergonomics with patient-centric comfort to enhance care experiences.
• Customer-Centric Innovation: Offers tailor-made solutions for evolving healthcare environments, emphasizing adaptability and excellence.
Recommended Dividend
The Board of Directors has recommended a dividend of ₹0.20 per equity share with a face value of ₹10 each.
Improved Export Performance
Mitsu has demonstrated strong growth in its export operations, recording an impressive 144% year-on-year increase in export value in FY25.
If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.
